Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. (2021) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution Implant-based CT estimation towards adaptive breast brachytherapy (2021) Dürrbeck C, Pflaum L, Schulz M, Kallis K, Geimer T, Abu-Hossin N, Strnad V, et al. Conference contribution Impact of patient positioning on interstitial multicatheter HDR brachytherapy of the breast (2021) Abu-Hossin N, Kallis K, Strnad V, Fietkau R, Bert C Conference contribution Quality assurance of curved catheter paths in interstitial brachytherapy using a constructed phantom (2021) Abu-Hossin N, Gulde S, Dürrbeck C, Strnad V, Fietkau R, Bert C Conference contribution Low-grade (polymorphous) adenocarcinoma of the middle ear mimicking a jugulotympanic paraganglioma. German version (2021) Mantsopoulos K, Fietkau R, Hornung J, Agaimy A, Iro H, Taha L Journal article Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy (2021) Zhou JG, Liang B, Liu JG, Jin SH, He SS, Frey B, Gu N, et al. Journal article Long-Term Results of the TARGIT-A Trial: More Questions than Answers (2021) Piroth MD, Strnad V, Krug D, Fastner G, Baumann R, Combs SE, Duma MN, et al. Journal article, Review article Implementation of double immune checkpoint blockade increases response rate to induction chemotherapy in head and neck cancer (2021) Semrau S, Gostian AO, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, et al. Journal article Neoadjuvant chemoradiation combined with regional hyperthermia in locally advanced or recurrent rectal cancer (2021) Ott O, Gani C, Lindner LH, Schmidt M, Lamprecht U, Abdel-Rahman S, Hinke A, et al. Journal article The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors (2021) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution